Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

BACKGROUND: A proportion of all immunocompetent patients treated for visceral leishmaniasis (VL) are known to relapse; however, the risk factors for relapse are not well understood. With the support of the Rajendra Memorial Research Institute (RMRI), Médecins Sans Frontières (MSF) implemented a prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Burza, Sakib, Sinha, Prabhat K., Mahajan, Raman, Lima, María Angeles, Mitra, Gaurab, Verma, Neena, Balsegaram, Manica, Das, Pradeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879206/
https://www.ncbi.nlm.nih.gov/pubmed/24392166
http://dx.doi.org/10.1371/journal.pntd.0002536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879206/
https://www.ncbi.nlm.nih.gov/pubmed/24392166
http://dx.doi.org/10.1371/journal.pntd.0002536

Ejemplares similares